Description
MIEBO (perfluorohexyloctane ophthalmic solution)
FDA Approves Perfluorohexyloctane Ophthalmic Solution for Dry Eye Disease
Perfluorohexyloctane ophthalmic solution (Miebo; Bausch + Lomb) has been approved by the FDA for the treatment signs and symptoms of dry eye disease, marking the first and only FDA-approved treatment for dry eye disease that directly targets tear evaporation.
MIEBO™ (perfluorohexyloctane ophthalmic solution) is indicated for the treatment of the signs and symptoms of dry eye disease (DED). Instill one drop of MIEBO four times daily into affected eye(s). Contact lenses should be removed prior to and for at least 30 minutes after the administration of MIEBO.
Get Access to MIEBO (perfluorohexyloctane ophthalmic solution) In India
On request it available to patient and doctors. Medvitaz Pharma is equipped to facilitate the distribution of MIEBO (perfluorohexyloctane ophthalmic solution) (prescription medications) worldwide and throughout India upon completion of necessary legal procedures, if applicable.
To inquire about the price of either the branded medication “MIEBO (perfluorohexyloctane ophthalmic solution)” or the generic version “perfluorohexyloctane ophthalmic solution” for personal use under patient-specific treatment in various cities including Delhi, Mumbai, Kolkata, Chennai, Bangalore, Hyderabad, Ahmedabad, Pune, Surat, Jaipur, Coimbatore, Noida, Gurgaon, Punjab, Chandigarh, Bhubaneswar, Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura, Sikkim, and others in India, please fill out the request form. Upon receiving your request and assessing the delivery process, we will provide you with an estimated price for the medication within 24 hours.
For any inquiries or assistance, please reach out to our Patient Support Team. We are available to assist you from Monday to Friday, between 9:00 and 19:00 IST. You can contact us via email at [email protected], toll-free at +91 8750295029, or through WhatsApp at +91-8750295029.